Overview
Lantheus develops radiopharmaceuticals used in nuclear medicine and molecular imaging for diagnosis and therapy selection.
Key products
Diagnostic radiotracers PET agents and imaging support products.
Strengths
Focus on molecular imaging innovation clinical trials and distribution networks.
Service and support
Offers clinical information safety data and logistics support for radiopharmaceutical handling.